GVN Center and Member Spotlight – Gene Morse

Members > Spotlights > Gene Morse GVN Center and Member Spotlight Gene Morse Professor University at Buffalo HIV and HCV Clinical Pharmacology Laboratory Center for Integrated Global Biomedical Sciences University at Buffalo, State University of New York What are you and your institution currently working on regarding COVID-19? (One paragraph) The GVN Center in Buffalo…

Read More

SARS-CoV-2 Salivary Tests

The benefits of saliva sampling for frequent and massive COVID-19 testing Saliva tests for detection of SARS-CoV-2 RNA and antigens are becoming widely available lately. What are the advantages and disadvantages of sampling saliva over the nasal swabs? Saliva sampling simply involves spitting into a collection container. Recently, the U.S. Food and Drug Administration (FDA)…

Read More

GVN Center and Member Spotlight – Pardis Sabeti

Members > Spotlights > Pardis Sabeti GVN Center and Member Spotlight Dr. Pardis Sabeti, MD, DPhil Professor, Harvard University School of Public Health Institute Member, Broad Institute of Harvard and MIT Investigator, Howard Hughes Medical Institute   What are you and your institution currently working on regarding COVID-19? As soon as the SARS-CoV-2 genomes were…

Read More

A Statement From the Leadership of the Global Virus Network on the Passing of Renowned Chinese Virologist Yi Zeng

A top cancer researcher and leader in public service is mourned Baltimore, Maryland, USA, July 23, 2020:  The Global Virus Network (GVN), a coalition comprised of the world’s preeminent human and animal virologists from 55 Centers of Excellence and 10 Affiliates in 32 countries, collectively mourns the passing of Professor Yi Zeng, MD, Academician of…

Read More

Antibody Dependent Enhancement and SARS-CoV-2

When Developing a SARS-CoV-2 Vaccine, Researchers Need to Consider that Antibodies May Enhance Infection Rather than Provide Protection There is encouraging news from recent clinical trials of SARS-CoV-2 vaccines, including several candidate vaccines that induce neutralizing antibodies with no apparent adverse effects. Their protective efficacy at preventing infections is not yet known, but will be…

Read More

Doherty Institute Report on ViaClean Products and SARS-CoV-2

Doherty Institute Report on TEST A: SARS-CoV-2 Viricidal Effectiveness Testing with ViaClean Products Doherty Institute Report on TEST B: SARS-CoV-2 Viricidal Effectiveness Testing with ViaClean Products

Read More

GVN: Forefront Of Virology COVID-19 Webinar Series featuring Dr. Erica Ollmann Saphire

WELCOME TO FEATURING DR. ERICA OLLMANN SAPHIRE – JULY 9, 2020 – “A GLOBAL COLLABORATION FOR ANTIBODY THERAPEUTICS” Erica Ollmann Saphire Director, GVN Center of Excellence GVN SARS-CoV-2 Task Force Member Professor, La Jolla Institute for Immunology, Scripps Research Institute, USA Bio sketch Erica Ollmann Saphire, Ph.D., is a Professor of the La Jolla Institute…

Read More

GVN Center and Member Spotlight – Donald Ingber

Members > Spotlights > Donald Ingber GVN Center and Member Spotlight Dr. Donald Ingber Founding Director, Wyss Institute at Harvard University Professor, Harvard Medical School & Boston Children’s Hospital Professor at the Harvard John A. Paulson School of Engineering and Applied Sciences What are you and your institution currently working on regarding COVID-19? The Wyss…

Read More

Further Insights into SARS-CoV-2 Genetic Variability: D614G

Can a single amino acid mutation in the spike protein affect the infectivity and immunogenicity of SARS-CoV-2? Recently, a great deal of attention has become focused on a specific SARS-CoV2 mutant in which amino acid residue 614 of the spike protein is changed from aspartic acid to the less bulky and more neutral glycine. This…

Read More

Cleveland Clinic and The University of Southern Denmark Join Global Virus Network to Combat Viral Diseases

GVN’s latest additions further bolster its 55 Centers for Excellence, expanding knowledge of viruses and treatment Baltimore, Maryland, USA, Tuesday, July 7, 2020: The Global Virus Network (GVN), comprising foremost experts around the world in every class of virus causing disease in humans and some animals, today announced the addition of Cleveland Clinic and the…

Read More